Page last updated: 2024-10-30

kynurenic acid and Psychoses, Drug

kynurenic acid has been researched along with Psychoses, Drug in 1 studies

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Research Excerpts

ExcerptRelevanceReference
"Kynurenic acid (KYNA) is an endogenous glutamate antagonist with a preferential action at the glycinesite of the N-methyl D-aspartate (NMDA)-receptor."5.32Kynurenic acid and schizophrenia. ( Engberg, G; Erhardt, S; Schwieler, L, 2003)
"Kynurenic acid (KYNA) is an endogenous glutamate antagonist with a preferential action at the glycinesite of the N-methyl D-aspartate (NMDA)-receptor."1.32Kynurenic acid and schizophrenia. ( Engberg, G; Erhardt, S; Schwieler, L, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erhardt, S1
Schwieler, L1
Engberg, G1

Other Studies

1 other study available for kynurenic acid and Psychoses, Drug

ArticleYear
Kynurenic acid and schizophrenia.
    Advances in experimental medicine and biology, 2003, Volume: 527

    Topics: Animals; Antipsychotic Agents; Dopamine; Glutamic Acid; Humans; Kynurenic Acid; Male; Models, Neurol

2003